Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
drug metabolite |
| gptkbp:alsoKnownAs |
norketamine
|
| gptkbp:CASNumber |
6740-82-5
|
| gptkbp:drugClass |
NMDA receptor antagonist
|
| gptkbp:hasMolecularFormula |
C12H14ClNO
|
| gptkbp:hasSMILES |
CN(C1CCCCC1C2=CC=CC=C2Cl)C=O
|
| gptkbp:hasUNII |
6Q1K1VJ1KE
|
| https://www.w3.org/2000/01/rdf-schema#label |
desmethylketamine
|
| gptkbp:isActiveMetaboliteOf |
gptkb:ketamine
|
| gptkbp:IUPACName |
2-(2-chlorophenyl)-2-(methylamino)cyclohexanone
|
| gptkbp:legalStatus |
unscheduled (varies by country)
|
| gptkbp:metabolism |
gptkb:ketamine
|
| gptkbp:molecularWeight |
223.7 g/mol
|
| gptkbp:parent |
gptkb:ketamine
|
| gptkbp:producedBy |
N-demethylation of ketamine
|
| gptkbp:PubChem_CID |
123591
CHEMBL2103832 |
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous intranasal |
| gptkbp:bfsParent |
gptkb:YFL-222
|
| gptkbp:bfsLayer |
7
|